HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, N. Articles by Miura, M. Search for Related Content PubMed PubMed Citation Articles by Sato, N. Articles by Miura, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 520-527, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Multivariate analysis of risk factors for thrombus formation in University of Tokyo ventricular assist device

N Sato, H Mohri, I Fujimasa, K Imachi, K Atsumi, Y Sezai, H Koyanagi, S Nitta and M Miura
Department of Thoracic and Cardiovascular Surgery, Tohoku University School of Medicine, Sendai, Japan.

Of 77 University of Tokyo ventricular assist devices used in a total of 70 patients at 21 institutions, 13 pumps were found to have macroscopic thrombus formations. Because 19 devices that were used for less than 24 hours showed no thrombus deposition, they were considered not to have been sufficiently exposed to the thrombogenic environment for macroscopic thrombus deposition and were removed from the subsequent multivariate study. A total of eight potential risk factors were assessed in relation to thrombosis. Prevalences of thrombus formation were compared between two groups with or without each of the risk factors. In a univariate analysis, the following categoric variables were demonstrated to be significantly associated with complications, in descending order of significance: use of gabexate mesilate (protease inhibitor) as an anticoagulant (p = 0.005), normal platelet count (p = 0.010), duration of support (p = 0.038), leukocytosis (p = 0.042), and minimum pumping flow (p = 0.042). Use of heparin and the consequent increase in activated clotting time showed no relationship. Multivariate discriminant analysis, which was done to identify risk factors rejecting cross correlation between each variable, demonstrated platelet count (p = 0.006), use of gabexate mesilate (p = 0.007), and minimum flow (p = 0.008) to have significant and independent risks. These results indicate the importance of maintaining pumping flow above a certain minimum level, addition of antiplatelet drugs to the antithrombogenic regimen, and nonuse of gabexate mesitate.

This article has been cited by other articles:

				G. J. Despotis, V. Levine, H. Joist, S. A. Santoro, and E. Mendeloff MULTIPLE EPISODES OF THROMBOSIS WITH BIVENTRICULAR SUPPORT DEVICES WITH INADEQUATE ANTICOAGULATION AND EVIDENCE OF ACCELERATED INTRAVASCULAR COAGULATION J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 419 - 422. [Full Text]

				H. Takano and T. Nakatani Ventricular Assist Systems: Experience in Japan With Toyobo Pump and Zeon Pump Ann. Thorac. Surg., January 1, 1996; 61(1): 317 - 322. [Abstract] [Full Text]

				D. Y. Loisance, F. Pouillart, C. Benvenuti, P. H. Deleuze, J.-P. Mazzucotelli, P. Le Besnerais, and A. Mourtada Mechanical Bridge to Transplantation: When Is Too Early? When Is Too Late? Ann. Thorac. Surg., January 1, 1996; 61(1): 388 - 390. [Abstract] [Full Text]